Biopharma Business

Tag "Imeglimin"

French Biotech Could Be Taking its Diabetes Drug to Phase III on its own

Poxel was able to score positive results for its type 2 diabetes drug in a Phase IIb study in Japan, preparing the company to go for a Phase III program. Poxel, one of

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements